Riccardo Riccardi Selected Research

Medulloblastoma

1/2020	Phase II study of temozolomide and topotecan (TOTEM) in children with relapsed or refractory extracranial and central nervous system tumors including medulloblastoma with post hoc Bayesian analysis: A European ITCC study.
10/2017	Phase I study of oral sonidegib (LDE225) in pediatric brain and solid tumors and a phase II study in children and adults with relapsed medulloblastoma.
5/2014	Temozolomide is an active agent in children with recurrent medulloblastoma/primitive neuroectodermal tumor: an Italian multi-institutional phase II trial.
1/2014	Gender effect in experimental models of human medulloblastoma: does the estrogen receptor β signaling play a role?
11/2013	Platinum compounds in children with cancer: toxicity and clinical management.
12/2012	Preclinical evaluation of the novel 7-substituted camptothecin Namitecan (ST1968) in paediatric tumour models.
11/2010	Phase I study of temozolomide combined with oral etoposide in children with recurrent or progressive medulloblastoma.
10/2010	Dual Inhibitor AEE788 Reduces Tumor Growth in Preclinical Models of Medulloblastoma.
6/2009	Antitumor effect in medulloblastoma cells by gefitinib: Ectopic HER2 overexpression enhances gefitinib effects in vivo.
2/2009	MicroRNA profiling in human medulloblastoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Riccardo Riccardi Research Topics

Disease

41	Neoplasms (Cancer) 01/2021 - 10/2002
18	Glioma (Gliomas) 01/2021 - 10/2002
11	Neuroblastoma 01/2014 - 10/2005
10	Medulloblastoma 01/2020 - 02/2009
6	Ependymoma 02/2021 - 06/2004
6	Primitive Neuroectodermal Tumors (PNET) 01/2020 - 02/2006
6	Brain Neoplasms (Brain Tumor) 11/2013 - 06/2004
5	Rhabdomyosarcoma 07/2012 - 09/2005
4	Infections 04/2019 - 01/2013
4	Hypersensitivity (Allergy) 01/2017 - 05/2002
4	Optic Nerve Glioma 02/2016 - 05/2011
4	Pain (Aches) 03/2014 - 03/2004
3	Carcinogenesis 01/2021 - 02/2009
3	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2017 - 05/2008
3	Vision Disorders (Hemeralopia) 02/2016 - 05/2011
3	Sarcoma (Soft Tissue Sarcoma) 07/2012 - 08/2003
3	Brain Injuries (Brain Injury) 11/2011 - 10/2005
3	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 11/2011 - 12/2002
3	Glioblastoma (Glioblastoma Multiforme) 01/2011 - 07/2006
2	Birth Weight (Birth Weights) 01/2020 - 01/2018
2	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2020 - 01/2018
2	Ewing Sarcoma (Sarcoma, Ewing) 01/2018 - 04/2012
2	Melanoma (Melanoma, Malignant) 12/2016 - 04/2006
2	Human Influenza (Influenza) 07/2014 - 12/2013
2	Fever (Fevers) 12/2013 - 01/2013
2	Nausea 11/2013 - 03/2013
2	Lymphoma (Lymphomas) 11/2013 - 12/2006
2	Anemia 08/2013 - 10/2002
2	Cancer Pain 03/2013 - 01/2009
2	Neoplasm Metastasis (Metastasis) 04/2012 - 08/2003
2	Atrophy 07/2011 - 05/2011
2	Coma (Comas) 04/2008 - 10/2005
2	Carcinoma (Carcinomatosis) 07/2006 - 09/2003
2	Astrocytoma (Pilocytic Astrocytoma) 06/2004 - 05/2002
2	Atrioventricular Block 08/2003 - 01/2003
1	COVID-19 10/2023
1	Dyspnea (Shortness of Breath) 01/2023
1	Tachypnea 01/2023

Drug/Important Bio-Agent (IBA)

12	Nerve Growth Factor (NGF)IBA 01/2021 - 06/2004
9	Temozolomide (Temodar)FDA LinkGeneric 01/2020 - 07/2006
6	Irinotecan (Camptosar)FDA LinkGeneric 12/2012 - 09/2005
5	Proteins (Proteins, Gene)FDA Link 02/2021 - 04/2008
5	Phosphotransferases (Kinase)IBA 01/2021 - 10/2005
4	Topotecan (Hycamtin)FDA LinkGeneric 01/2020 - 10/2005
4	Carboplatin (JM8)FDA LinkGeneric 01/2017 - 05/2002
4	Etoposide (VP 16)FDA LinkGeneric 08/2014 - 10/2002
4	Antineoplastic Agents (Antineoplastics)IBA 10/2013 - 01/2005
4	ErbB Receptors (EGF Receptor)IBA 09/2012 - 12/2006
3	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2021 - 07/2006
3	Nerve Growth Factors (Neurotrophins)IBA 01/2021 - 06/2004
3	Epidermal Growth Factor (EGF)IBA 11/2017 - 12/2008
3	Ophthalmic Solutions (Eye Drops)IBA 02/2016 - 05/2011
3	Platinum Compounds (Compounds, Platinum)IBA 01/2016 - 10/2013
3	DNA (Deoxyribonucleic Acid)IBA 08/2014 - 07/2006
3	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 12/2013 - 06/2004
3	Brain-Derived Neurotrophic Factor (BDNF)IBA 12/2013 - 06/2004
3	CytokinesIBA 12/2013 - 05/2008
3	Interleukin-6 (Interleukin 6)IBA 12/2013 - 05/2008
3	Cisplatin (Platino)FDA LinkGeneric 11/2013 - 10/2002
3	Methotrexate (Mexate)FDA LinkGeneric 10/2013 - 12/2002
3	CamptothecinIBA 12/2012 - 10/2005
3	Gefitinib (Iressa)FDA Link 09/2012 - 12/2008
3	RetinoidsIBA 08/2012 - 03/2007
3	Imatinib Mesylate (Gleevec)FDA Link 03/2007 - 10/2005
3	TrabectedinIBA 09/2005 - 08/2003
2	Protein Kinases (Protein Kinase)IBA 01/2021 - 09/2008
2	NucleotidesIBA 07/2020 - 12/2006
2	Surface-Active Agents (Surfactants)IBA 01/2020 - 01/2018
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2018 - 04/2012
2	Ketamine FDA LinkGeneric 03/2014 - 12/2011
2	InterleukinsIBA 12/2013 - 01/2013
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 11/2013 - 01/2011
2	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2013 - 08/2003
2	Biomarkers (Surrogate Marker)IBA 10/2013 - 11/2011
2	BilirubinIBA 07/2013 - 09/2003
2	Opioid Analgesics (Opioids)IBA 03/2013 - 01/2009
2	Buprenorphine (Subutex)FDA LinkGeneric 03/2013 - 01/2009
2	namitecanIBA 12/2012 - 07/2012
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 09/2012 - 07/2006
2	AEE 788 (AEE788)IBA 09/2012 - 10/2010
2	3- (4'- hydroxy- 3'- adamantylbiphenyl- 4- yl)acrylic acidIBA 08/2012 - 03/2007
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2012 - 10/2010
2	Type I DNA Topoisomerases (Topoisomerase I)IBA 07/2012 - 02/2006
2	ST 1481 (Gimatecan)IBA 09/2010 - 10/2005
2	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 12/2006 - 07/2006
2	tyrosine receptor (receptor, tyrosine)IBA 07/2006 - 10/2005
1	Antiviral Agents (Antivirals)IBA 10/2023
1	Oxygen (Dioxygen)IBA 01/2023
1	Histones (Histone)IBA 02/2021
1	OTX015IBA 02/2021
1	AZD 6244IBA 01/2021
1	trkA ReceptorIBA 01/2021

Therapy/Procedure

20	Therapeutics 02/2021 - 07/2003
14	Drug Therapy (Chemotherapy) 01/2018 - 10/2002
6	Radiotherapy 02/2015 - 10/2002
4	Investigational Therapies (Experimental Therapy) 01/2014 - 06/2010
4	Catheters 07/2010 - 04/2002
3	Cryosurgery 11/2006 - 01/2003
3	Catheter Ablation 03/2004 - 01/2003
2	Radiofrequency Ablation 08/2003 - 11/2002